Additionally, AGTR1 upregulation decreased p53 and p21 expressions as well as the proportions of SA-β-gal- and SAHF-positive cells for sorafenib-exposed HCC cells. The gene discussed is AGTR1; the disease is hepatocellular carcinoma.